A

  • Adenovirus Abnormal Changes in IL-13 and IL-17A Serum Levels in Children with Adenovirus Pneumonia and their Diagnostic Value [Volume 21, Issue 1, 2024, Pages 81-88]

  • Ankylosing Spondylitis Evaluation of PD-1 Gene Expression Profile and Methylation of the Regulatory Regions in Patients with Ankylosing Spondylitis [Volume 21, Issue 2, 2024, Pages 6-6]

  • Antibody Response Letter to the Editor Regarding “Antibody Production after COVID-19 Vaccination in Patients with Inborn Errors of Immunity” [Volume 21, Issue 1, 2024, Pages 101-102]

  • Antinuclear Antibody The Ratio of Peripheral Blood Natural Killer Cells is not a Solid Surrogate Immune Index in Unexplained Recurrent Miscarriage [Volume 21, Issue 1, 2024, Pages 15-26]

  • Asthma Intervention with ICOSL Antibodies Alleviates Inflammatory Infiltrations in Mice with Neutrophilic Asthma [Volume 21, Issue 1, 2024, Pages 53-64]

B

  • Bladder Cancer Natural Killer Cell Subsets in Tumor Draining Lymph Nodes of Patients with Bladder Cancer and Their Clinical Implications [Volume 21, Issue 2, 2024, Pages 2-2]

  • Booster Vaccination Letter to the Editor Regarding “Antibody Production after COVID-19 Vaccination in Patients with Inborn Errors of Immunity” [Volume 21, Issue 1, 2024, Pages 101-102]

  • Brain Tumors Serum Interleukin-38 and Tumor-Infiltrating Lymphocytes in Primary Brain Tumors [Volume 21, Issue 1, 2024, Pages 65-73]

  • Breast cancer Glycyrrhiza Glabra Extract Modulates Type 1 T Helper (TH1) and Regulatory T Cell-Related Immune Responses in an Animal Model of Breast Cancer [Volume 21, Issue 2, 2024, Pages 3-3]

  • Bronchoalveolar Lavage Fluid IL-27 Levels in Bronchoalveolar Lavage Fluid in Children with Post-infectious Bronchiolitis Obliterans [Volume 21, Issue 1, 2024, Pages 74-80]

C

  • CD33+CD11b+ Cell Outcome of Cyclophosphamide Treatment Following Hematopoietic Stem Cell Transplantation in a Thalassemia Patient: A Case Study [Volume 21, Issue 2, 2024, Pages 7-7]

  • CD56 Immunohistochemical Evaluation of NKP46 Receptor Expression and the Number of NK Cells in the Endometrium of Patients with Endometriosis [Volume 21, Issue 1, 2024, Pages 27-36]

  • Complementary therapies Functional Property and Regulatory Mechanism of Macrophages in Complementary and Alternative Medicine: From Bench to Clinic [Volume 21, Issue 2, 2024, Pages 1-1]

  • COVID-19 Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice [Volume 21, Issue 1, 2024, Pages 1-14]

  • COVID-19 Letter to the Editor Regarding “Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice” [Volume 21, Issue 2, 2024, Pages 8-8]

  • COVID-19 Vaccination Letter to the Editor Regarding “Antibody Production after COVID-19 Vaccination in Patients with Inborn Errors of Immunity” [Volume 21, Issue 1, 2024, Pages 101-102]

  • Cyclophosphamide Outcome of Cyclophosphamide Treatment Following Hematopoietic Stem Cell Transplantation in a Thalassemia Patient: A Case Study [Volume 21, Issue 2, 2024, Pages 7-7]

  • Cytokines Glycyrrhiza Glabra Extract Modulates Type 1 T Helper (TH1) and Regulatory T Cell-Related Immune Responses in an Animal Model of Breast Cancer [Volume 21, Issue 2, 2024, Pages 3-3]

D

  • DNA Methylation Evaluation of PD-1 Gene Expression Profile and Methylation of the Regulatory Regions in Patients with Ankylosing Spondylitis [Volume 21, Issue 2, 2024, Pages 6-6]

  • Draining Lymph Node Natural Killer Cell Subsets in Tumor Draining Lymph Nodes of Patients with Bladder Cancer and Their Clinical Implications [Volume 21, Issue 2, 2024, Pages 2-2]

E

  • Endometriosis Immunohistochemical Evaluation of NKP46 Receptor Expression and the Number of NK Cells in the Endometrium of Patients with Endometriosis [Volume 21, Issue 1, 2024, Pages 27-36]

  • Epigenetics Evaluation of PD-1 Gene Expression Profile and Methylation of the Regulatory Regions in Patients with Ankylosing Spondylitis [Volume 21, Issue 2, 2024, Pages 6-6]

F

  • Flow cytometry Evaluation of Monocyte Subpopulations in Patients with Systemic Sclerosis and its Association with Clinical Manifestations of the Disease: a Cross-sectional Controlled Study [Volume 21, Issue 2, 2024, Pages 4-4]

G

  • Gene expression Evaluation of PD-1 Gene Expression Profile and Methylation of the Regulatory Regions in Patients with Ankylosing Spondylitis [Volume 21, Issue 2, 2024, Pages 6-6]

  • Glycyrrhiza Glabra Glycyrrhiza Glabra Extract Modulates Type 1 T Helper (TH1) and Regulatory T Cell-Related Immune Responses in an Animal Model of Breast Cancer [Volume 21, Issue 2, 2024, Pages 3-3]

  • GVHD Outcome of Cyclophosphamide Treatment Following Hematopoietic Stem Cell Transplantation in a Thalassemia Patient: A Case Study [Volume 21, Issue 2, 2024, Pages 7-7]

H

  • HSCT Outcome of Cyclophosphamide Treatment Following Hematopoietic Stem Cell Transplantation in a Thalassemia Patient: A Case Study [Volume 21, Issue 2, 2024, Pages 7-7]

I

  • IDO Outcome of Cyclophosphamide Treatment Following Hematopoietic Stem Cell Transplantation in a Thalassemia Patient: A Case Study [Volume 21, Issue 2, 2024, Pages 7-7]

  • IL-17 MicroRNA-150 Deletion Reduces the Occurrence and Severity of Rheumatoid Arthritis by Inhibiting IL-17 [Volume 21, Issue 1, 2024, Pages 89-100]

  • IL-22 Outcome of Cyclophosphamide Treatment Following Hematopoietic Stem Cell Transplantation in a Thalassemia Patient: A Case Study [Volume 21, Issue 2, 2024, Pages 7-7]

  • IL-27 IL-27 Levels in Bronchoalveolar Lavage Fluid in Children with Post-infectious Bronchiolitis Obliterans [Volume 21, Issue 1, 2024, Pages 74-80]

  • Immunogenicity Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice [Volume 21, Issue 1, 2024, Pages 1-14]

  • Immunogenicity Letter to the Editor Regarding “Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice” [Volume 21, Issue 2, 2024, Pages 8-8]

  • Inborn Errors of Immunity (IEI) Letter to the Editor Regarding “Antibody Production after COVID-19 Vaccination in Patients with Inborn Errors of Immunity” [Volume 21, Issue 1, 2024, Pages 101-102]

  • Inducible T Cell Co-Stimulator Ligand Intervention with ICOSL Antibodies Alleviates Inflammatory Infiltrations in Mice with Neutrophilic Asthma [Volume 21, Issue 1, 2024, Pages 53-64]

  • Inflammation Functional Property and Regulatory Mechanism of Macrophages in Complementary and Alternative Medicine: From Bench to Clinic [Volume 21, Issue 2, 2024, Pages 1-1]

  • Inflammation Evaluation of Monocyte Subpopulations in Patients with Systemic Sclerosis and its Association with Clinical Manifestations of the Disease: a Cross-sectional Controlled Study [Volume 21, Issue 2, 2024, Pages 4-4]

  • Inflammatory bowel disease Sulforaphane Regulates Macrophage M1/M2 Polarization to Attenuate Macrophage-induced Caco-2 Cell Injury in an Inflammatory Environment [Volume 21, Issue 1, 2024, Pages 37-52]

  • Interferon Beta The Effect of Interferon Beta and Natalizumab on miR-20b Expression in Patients with Relapsing-Remitting Multiple Sclerosis is Potentially Mediated by Modulation of the Jak–STAT Signaling Pathway: A Case-control Study [Volume 21, Issue 2, 2024, Pages 5-5]

  • Interleukin-13 Abnormal Changes in IL-13 and IL-17A Serum Levels in Children with Adenovirus Pneumonia and their Diagnostic Value [Volume 21, Issue 1, 2024, Pages 81-88]

  • Interleukin-17A Abnormal Changes in IL-13 and IL-17A Serum Levels in Children with Adenovirus Pneumonia and their Diagnostic Value [Volume 21, Issue 1, 2024, Pages 81-88]

  • Interleukin-38 Serum Interleukin-38 and Tumor-Infiltrating Lymphocytes in Primary Brain Tumors [Volume 21, Issue 1, 2024, Pages 65-73]

L

  • Long-Term Vaccine Efficacy Letter to the Editor Regarding “Antibody Production after COVID-19 Vaccination in Patients with Inborn Errors of Immunity” [Volume 21, Issue 1, 2024, Pages 101-102]

M

  • Macrophage Sulforaphane Regulates Macrophage M1/M2 Polarization to Attenuate Macrophage-induced Caco-2 Cell Injury in an Inflammatory Environment [Volume 21, Issue 1, 2024, Pages 37-52]

  • Macrophage Functional Property and Regulatory Mechanism of Macrophages in Complementary and Alternative Medicine: From Bench to Clinic [Volume 21, Issue 2, 2024, Pages 1-1]

  • MicroRNA-150 MicroRNA-150 Deletion Reduces the Occurrence and Severity of Rheumatoid Arthritis by Inhibiting IL-17 [Volume 21, Issue 1, 2024, Pages 89-100]

  • Monocytes Evaluation of Monocyte Subpopulations in Patients with Systemic Sclerosis and its Association with Clinical Manifestations of the Disease: a Cross-sectional Controlled Study [Volume 21, Issue 2, 2024, Pages 4-4]

  • Multiple Sclerosis The Effect of Interferon Beta and Natalizumab on miR-20b Expression in Patients with Relapsing-Remitting Multiple Sclerosis is Potentially Mediated by Modulation of the Jak–STAT Signaling Pathway: A Case-control Study [Volume 21, Issue 2, 2024, Pages 5-5]

N

  • Natalizumab The Effect of Interferon Beta and Natalizumab on miR-20b Expression in Patients with Relapsing-Remitting Multiple Sclerosis is Potentially Mediated by Modulation of the Jak–STAT Signaling Pathway: A Case-control Study [Volume 21, Issue 2, 2024, Pages 5-5]

  • Natural Killer (NK) Cells Natural Killer Cell Subsets in Tumor Draining Lymph Nodes of Patients with Bladder Cancer and Their Clinical Implications [Volume 21, Issue 2, 2024, Pages 2-2]

  • Neutralization Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice [Volume 21, Issue 1, 2024, Pages 1-14]

  • Neutralization Letter to the Editor Regarding “Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice” [Volume 21, Issue 2, 2024, Pages 8-8]

  • Neutrophils Intervention with ICOSL Antibodies Alleviates Inflammatory Infiltrations in Mice with Neutrophilic Asthma [Volume 21, Issue 1, 2024, Pages 53-64]

  • NK Cells The Ratio of Peripheral Blood Natural Killer Cells is not a Solid Surrogate Immune Index in Unexplained Recurrent Miscarriage [Volume 21, Issue 1, 2024, Pages 15-26]

  • NKp46 Immunohistochemical Evaluation of NKP46 Receptor Expression and the Number of NK Cells in the Endometrium of Patients with Endometriosis [Volume 21, Issue 1, 2024, Pages 27-36]

  • NK Subsets Natural Killer Cell Subsets in Tumor Draining Lymph Nodes of Patients with Bladder Cancer and Their Clinical Implications [Volume 21, Issue 2, 2024, Pages 2-2]

  • Nrf2/ARE Sulforaphane Regulates Macrophage M1/M2 Polarization to Attenuate Macrophage-induced Caco-2 Cell Injury in an Inflammatory Environment [Volume 21, Issue 1, 2024, Pages 37-52]

P

  • Pathology Intervention with ICOSL Antibodies Alleviates Inflammatory Infiltrations in Mice with Neutrophilic Asthma [Volume 21, Issue 1, 2024, Pages 53-64]

  • Pediatrics Abnormal Changes in IL-13 and IL-17A Serum Levels in Children with Adenovirus Pneumonia and their Diagnostic Value [Volume 21, Issue 1, 2024, Pages 81-88]

  • Post-Infectious Bronchiolitis Obliterans IL-27 Levels in Bronchoalveolar Lavage Fluid in Children with Post-infectious Bronchiolitis Obliterans [Volume 21, Issue 1, 2024, Pages 74-80]

  • Potency Letter to the Editor Regarding “Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice” [Volume 21, Issue 2, 2024, Pages 8-8]

  • Programmed Cell Death 1 Evaluation of PD-1 Gene Expression Profile and Methylation of the Regulatory Regions in Patients with Ankylosing Spondylitis [Volume 21, Issue 2, 2024, Pages 6-6]

R

  • Recurrent Miscarriage The Ratio of Peripheral Blood Natural Killer Cells is not a Solid Surrogate Immune Index in Unexplained Recurrent Miscarriage [Volume 21, Issue 1, 2024, Pages 15-26]

  • Regulatory T cells Glycyrrhiza Glabra Extract Modulates Type 1 T Helper (TH1) and Regulatory T Cell-Related Immune Responses in an Animal Model of Breast Cancer [Volume 21, Issue 2, 2024, Pages 3-3]

  • Rheumatoid Arthritis MicroRNA-150 Deletion Reduces the Occurrence and Severity of Rheumatoid Arthritis by Inhibiting IL-17 [Volume 21, Issue 1, 2024, Pages 89-100]

S

  • SARS-CoV-2 Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice [Volume 21, Issue 1, 2024, Pages 1-14]

  • Severe Pneumonia Abnormal Changes in IL-13 and IL-17A Serum Levels in Children with Adenovirus Pneumonia and their Diagnostic Value [Volume 21, Issue 1, 2024, Pages 81-88]

  • Sulforaphane Sulforaphane Regulates Macrophage M1/M2 Polarization to Attenuate Macrophage-induced Caco-2 Cell Injury in an Inflammatory Environment [Volume 21, Issue 1, 2024, Pages 37-52]

  • Systemic Sclerosis Evaluation of Monocyte Subpopulations in Patients with Systemic Sclerosis and its Association with Clinical Manifestations of the Disease: a Cross-sectional Controlled Study [Volume 21, Issue 2, 2024, Pages 4-4]

T

  • TH1 Cells Glycyrrhiza Glabra Extract Modulates Type 1 T Helper (TH1) and Regulatory T Cell-Related Immune Responses in an Animal Model of Breast Cancer [Volume 21, Issue 2, 2024, Pages 3-3]

  • Thyroglobulin Antibodies The Ratio of Peripheral Blood Natural Killer Cells is not a Solid Surrogate Immune Index in Unexplained Recurrent Miscarriage [Volume 21, Issue 1, 2024, Pages 15-26]

  • Thyroid Peroxidase Antibodies The Ratio of Peripheral Blood Natural Killer Cells is not a Solid Surrogate Immune Index in Unexplained Recurrent Miscarriage [Volume 21, Issue 1, 2024, Pages 15-26]

  • Tumor-Infiltrating Lymphocytes Serum Interleukin-38 and Tumor-Infiltrating Lymphocytes in Primary Brain Tumors [Volume 21, Issue 1, 2024, Pages 65-73]

U

  • Uterine NK Cells Immunohistochemical Evaluation of NKP46 Receptor Expression and the Number of NK Cells in the Endometrium of Patients with Endometriosis [Volume 21, Issue 1, 2024, Pages 27-36]

V

  • Vaccine Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice [Volume 21, Issue 1, 2024, Pages 1-14]

  • Vaccines Letter to the Editor Regarding “Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice” [Volume 21, Issue 2, 2024, Pages 8-8]